April 26, 2007 - AutoPulse Offers Data Management

INVESTOR CONTACT:

A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655

MEDIA CONTACT:

Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
degan@zoll.com

 

ZOLL Introduces World's First Assisted Circulation Device to Offer Data Management

New AutoPulse Incorporates Major Enhancements

April 26, 2007—CHELMSFORD, MASS.—ZOLL Medical Corporation (Nasdaq GS-ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced the release of a new model of the ZOLL AutoPulse® Non-Invasive Cardiac Support Pump, which can document, store and upload device and patient data.

The new capability allows uploading of information from as many as four patients to ZOLL RescueNet® Code Review or CodeNet® software via an infrared communications port on the AutoPulse. The AutoPulse data is combined with manual CPR data, defibrillator and other resuscitation data in a user-friendly Code Summary format that can document virtually all CPR and resuscitation efforts over an entire event.  Quality measures, such as CPR compression depth, rate and interruptions, as well as all AutoPulse use data, are all easily reviewed.  In addition, its new on-screen timer enhances American Heart Association Guidelines compliance by allowing the user to see in real time the exact compression time, and, perhaps more importantly, “no-flow” time.

According to Richard A. Packer, President and Chief Executive Officer of ZOLL, “We’ve taken a revolutionary product and made it even better. In addition to providing consistent, high-quality chest compressions that improve blood flow, minimize no-flow time, and increase the likelihood of survival, the benefit of better documentation and data management should further advance resuscitation efforts,” he said. 

Despite these major enhancements, the new AutoPulse is fully compatible with existing AutoPulse units since, like ZOLL defibrillators, both versions share an identical user interface. 

Other new features include:

  • Lighter in weight by 10%
  • Improved ‘cleanability’ with fewer areas where contaminants can collect
  • Rugged molded bumpers for increased durability

About AutoPulse

The AutoPulse helps provide the consistent, uninterrupted chest compressions called for by the 2005 American Heart Association Guidelines. It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes a wider area of the chest in a consistent, uninterrupted “hands-free” manner, improving blood flow to the heart and brain during cardiac arrest.* Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.

NOTE:  Photos of the new AutoPulse are available at http://www.zoll.com/page.aspx?id=1116

Certain statements contained in this press release regarding matters that are not historical facts are
“forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on February 9, 2007.

* Clinical references available upon request.

©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105.  RescueNet is a trademark of ZOLL Medical Corporation. AutoPulse, LifeBand, CodeNet, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.

 

 

# # #